$2.55
0.02[0.79%]
At close: Apr 25
$2.55
0[0.00%]
After Hours: 6:38PM EDT
DiaMedica Therapeutics
(NASDAQ:DMAC)DiaMedica Therapeutics Stock (NASDAQ:DMAC), Insider Trading Activity
DiaMedica Therapeutics: Insider buying and selling updated today.
Insider Shares Owned
1.513M
Insider Percentage Owned
3.99%
Institutional Shares Held
2.173M
Institutional Percentage Held
5.73%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2023 | David Wambeke | CHIEF BUSINESS OFFICER | 20K | $2.46 | $49.20K | BUY | 3.94% | 527.114K | Nov 16 | View |
| Jun 27, 2023 | Thomas Koch VonAB TomEnterpriseAB Private TomEqt | 10% OWNER | 1.470588M | $3.40 | $5.00M | BUY | 51.49% | 4.326435M | Jun 23 | View |
| Jun 26, 2023 | Michael Randall Giuffre | DIRECTOR | 50K | $3.91 | $254.15K | BUY | 15.80% | 366.425K | Jun 23 | View |
| Jun 26, 2023 | John Dietrich Pauls | PRESIDENT AND CEO | 12.787K | $3.91 | $50.00K | BUY | 22.91% | 68.591K | Jun 23 | View |
| Jun 26, 2023 | Pauling Charles Semba | DIRECTOR | 12.787K | $3.91 | $50.00K | BUY | 74.53% | 29.943K | Jun 23 | View |
| Jun 26, 2023 | Scott Kellen | CFO AND SECRETARY | 10K | $3.91 | $39.10K | BUY | 44.86% | 32.29K | Jun 23 | View |
| Jun 26, 2023 | David Wambeke | CHIEF BUSINESS OFFICER | 38.364K | $3.91 | $150.00K | BUY | 8.18% | 507.114K | Jun 23 | View |
| Jun 26, 2023 | Richard Pilnik | DIRECTOR | 38.363K | $3.91 | $150.00K | BUY | 18.28% | 248.245K | Jun 23 | View |
| Apr 11, 2023 | David Wambeke | CHIEF BUSINESS OFFICER | 468.75K | $1.60 | $750.00K | BUY | ∞ | 468.75K | Apr 10 | View |
| Dec 12, 2022 | Michael Randall Giuffre | DIRECTOR | 57.079K | $1.42 | $81.02K | BUY | 25.46% | 281.295K | Dec 08 - Dec 09 | View |
| Dec 08, 2022 | Michael Randall Giuffre | DIRECTOR | 24.874K | $1.40 | $34.71K | BUY | 12.48% | 224.216K | Dec 06 - Dec 07 | View |
| Dec 06, 2022 | Thomas Koch VonAB TomEnterpriseAB Private TomEqt | 10% OWNER | 0 | $1.24 | $0.00 | p / s | 0.00% | 2.855847M | Dec 02 | View |
| Dec 05, 2022 | Richard Pilnik | DIRECTOR | 35K | $1.39 | $48.49K | BUY | 29.33% | 154.327K | Dec 05 | View |
| Dec 05, 2022 | Michael Randall Giuffre | DIRECTOR | 819 | $1.19 | $974.61 | BUY | 0.41% | 199.342K | Dec 01 | View |
| Dec 01, 2022 | Michael Randall Giuffre | DIRECTOR | 67.228K | $1.20 | $80.46K | BUY | 40.89% | 231.639K | Nov 29 - Dec 01 | View |
| Jul 21, 2022 | Thomas Koch VonAB TomEnterprise | 10% OWNER | 207.974K | $1.33 | $275.90K | BUY | 7.85% | 2.855827M | Jul 08 | View |
| Sep 15, 2021 | HARRY ALCORN JR | SVP, CLINICAL OPERATIONS | 15K | $3.80 | $56.96K | BUY | 51.76% | 43.981K | Sep 15 | View |
| Aug 17, 2021 | Amy Burroughs | DIRECTOR | 44.95K | $3.15 | $141.59K | BUY | ∞ | 44.95K | Aug 16 | View |
| Aug 17, 2021 | Richard Pilnik | DIRECTOR | 15K | $3.27 | $49.06K | BUY | 18.62% | 95.565K | Aug 16 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.